The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope).

Clinical breast cancer

Volumn 3 Suppl 4, Issue , 2003, Pages

  Holmberg, Leona A ^a   Oparin, Dimitri V ^a   Gooley, Ted ^a   Sandmaier, Brenda M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 15-3 ANTIGEN; CANCER VACCINE; HEMOCYANIN; SIALYL TN ANTIGEN KEYHOLE LIMPET HEMOCYANIN CONJUGATE; SIALYL-TN ANTIGEN-KEYHOLE-LIMPET HEMOCYANIN CONJUGATE; TUMOR ANTIGEN;

ARTICLE; AUTOTRANSPLANTATION; BREAST TUMOR; CELL PROLIFERATION; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HUMAN; IMMUNOLOGY; OVARY TUMOR; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; SURVIVAL; TREATMENT OUTCOME;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CANCER VACCINES; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HEMOCYANIN; HUMANS; OVARIAN NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0346994560     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/cbc.2003.s.004     Document Type: Article

References (0)